BiPolar Clinical Trial
Official title:
A Nonrandomized, Open-Label, Multicenter, Phase 1 Study to Assess the Safety and Pharmacokinetics of ADASUVE® (STACCATO® Loxapine for Inhalation) at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication
This study is to assess the pharmacokinetics of loxapine and will be using plasma concentration data obtained over 48 hours after administration of the study drug
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT02133170 -
"Mindfulness vs Psychoeducation in Bipolar Disorder"
|
N/A | |
| Completed |
NCT02189057 -
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression
|
N/A | |
| Completed |
NCT00666432 -
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
|
||
| Completed |
NCT00300820 -
Perspectives of Individuals With Bipolar Disorder and Siblings of Individuals With Bipolar Disorder; A Telephone Interview Study
|
N/A | |
| Terminated |
NCT01131559 -
Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
|
Phase 3 | |
| Recruiting |
NCT01047215 -
Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine
|
Phase 4 | |
| Enrolling by invitation |
NCT00969930 -
Genetic Association Study Between Single Nucleotide Polymorphisms (SNPs) and Cognitive Performance in Young Bipolar Type I Patients: LICAVALGENE
|
N/A |